Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-06 Sale |
2025-01-07 8:13 pm |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
2,446 | $7.63 | $18,663 | 137,618 (Direct) |
View |
| 2024-06-26 Sale |
2024-06-27 8:00 pm |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
5,489 | $4.75 | $26,073 | 83,982 (Direct) |
View |
| 2024-05-31 Sale |
2024-06-03 8:00 pm |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
2,002 | $6.09 | $12,192 | 89,471 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:05 pm |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
1,617 | $6.74 | $10,899 | 120,773 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
73 | $28.53 | $2,083 | 18,536 (Direct) |
View |
| 2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
261 | $6.51 | $1,699 | 5,809 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 8:11 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
3,144 | $0.37 | $1,163 | 285,201 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
3,504 | $1.3 | $4,555 | 526,345 (Direct) |
View |
| 2021-10-26 Sale |
2021-10-28 8:02 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K CHIEF MEDICAL OFFICER |
12,757 | $1.8 | $22,963 | 291,849 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:26 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K CHIEF MEDICAL OFFICER |
3,034 | $5.77 | $17,506 | 300,962 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-06 Option Award |
2025-01-07 8:13 pm |
N/A 2035-01-05 |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
55,300 | $0 | 137,618 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:05 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
35,800 | $0 | 120,773 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
115,164 | $0 | 151,616 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
17,916 | $0 | 36,452 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
576 | $0 | 576 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
12,800 | $0 | 18,536 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
238,000 | $0 | 526,345 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:59 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
137,500 | $0 | 413,996 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:28 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
81,000 | $0 | 276,496 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:47 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
19,000 | $0 | 195,496 (Direct) |
View |